Pancreatic Cancer Trial, Recruiting NCT07407231 Sponsor: Institute of Oncology Ljubljana Condition: Pancreatic Cancer
Back to Pancreatic Cancer

Pancreatic Cancer Trial, Recruiting

NCT07407231
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be 18 years old or older
  • You have been diagnosed with pancreatic cancer that has grown locally and cannot be removed by surgery
  • You have already received chemotherapy as your first treatment, followed by a precise, targeted type of radiation therapy called SBRT, at one of the clinics taking part in this study
  • You are able and willing to sign a form giving your consent to take part

Who may not be able to join:

  • Your pancreatic cancer has spread to other parts of the body (such as other organs)
  • You have already received one or more rounds of chemotherapy or other systemic treatments for your locally advanced pancreatic cancer before this study
  • Your cancer got worse or continued to grow after your initial chemotherapy, before you received the SBRT radiation treatment
  • You have any other health condition that the trial doctor believes could affect your ability to take part in or complete the study (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 01 5879 220

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Institute of Oncology Ljubljana
Registry
ClinicalTrials.gov
Start date
1 September 2021
Est. completion
30 September 2024

Where this trial is recruiting

🇸🇮 Slovenia

Primary endpoints

Treatment Response Rate After SBRT

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov